Eiger BioPharmaceuticals, Inc. announced the appointments of Christopher Kurtz as Chief Technical Officer and Sarah Mathieson as Senior Vice President, Corporate Affairs. Chris Kurtz brings nearly 30 years of technical operations and global biopharmaceutical manufacturing experience to Eiger. He has successfully established supply capabilities and navigated numerous products across late-stage development, scale-up, approval, and commercialization.

Previously, Chris served as Executive Vice President of Technical Operations at Cidara Therapeutics where he established and validated the supply chain for a novel antifungal agent. Sarah Mathieson brings 25 years of biopharmaceutical corporate communications experience to Eiger. She most recently led Corporate Communications, Patient Advocacy and Engagement at Adamas Pharmaceuticals which was acquired by Supernus Pharmaceuticals.